Industry Research Reports

Home > Reports > Medical Care > Global Oncolytic Virus Therapy Market Research Report 2025

Global Oncolytic Virus Therapy Market Research Report 2025

Industry: Medical Care

Published Date: 2025-08-13

Pages: 67 Pages

Report ld: 3470552

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Oncolytic Virus Therapy Market Size(US$)

CAGR 2025-2031

10.4%

Market Size,2031

USD 213

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 118 million

Market Forecast in 2031(Value)

US$ 213 million

CAGR

10.4%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Oncolytic Virus Therapy was valued at US$ 106 million in the year 2024 and is projected to reach a revised size of US$ 213 million by 2031, growing at a CAGR of 10.4% during the forecast period.

Oncolytic Virus Therapy is an innovative cancer treatment approach that employs genetically modified viruses to selectively infect and destroy tumor cells while activating the host’s immune system to launch a systemic anti-tumor response. These viruses induce direct oncolysis and stimulate immunogenic cell death, positioning them as a pivotal class in immuno-oncology. Unlike chemotherapy or radiotherapy, this modality offers enhanced tumor selectivity, reduced toxicity, and strong synergistic potential when combined with immune checkpoint inhibitors. Products like Talimogene laherparepvec (T-VEC) have received FDA approval, showing promising efficacy in melanoma and drawing increasing R&D and commercial attention from global pharmaceutical companies.

With breakthroughs in immuno-oncology and the advancement of precision medicine, oncolytic virus therapy is entering a period of rapid growth. Global regulatory bodies are encouraging innovation through frameworks like the FDA's Breakthrough Therapy designation and the EU’s PRIME program, facilitating clinical acceleration and early commercialization. The increasing incidence of cancer, particularly advanced solid tumors, underscores the unmet demand for novel mechanisms of action. Furthermore, leading biopharmaceutical companies are actively investing in M&A and strategic partnerships in this space, significantly expanding their pipelines. Since 2023, several oncolytic virus candidates have advanced into Phase III trials, marking a clear shift toward industrial scalability.

Despite promising prospects, several key challenges persist in the development of oncolytic virus therapies. Efficient in vivo delivery and tumor-specific targeting remain technical hurdles, especially in patients with immunosuppressive microenvironments or rapid viral clearance. Clinical trials are resource-intensive, requiring long timelines, significant funding, and multidisciplinary collaboration spanning virology, immunology, and translational medicine. Safety concerns also linger, including risks of off-target infection and systemic inflammation. Additionally, the industry still lacks a broad base of commercially successful precedents, leading to cautious investment sentiment and uncertain return on investment timelines.

The downstream demand for innovative cancer therapies is rapidly rising, with oncolytic viruses increasingly recognized as critical components of next-generation immunotherapy combinations. In difficult-to-treat tumors such as glioblastoma, pancreatic cancer, and bladder cancer, preliminary data indicates enhanced efficacy when combined with checkpoint inhibitors like PD-1/PD-L1. Clinical practitioners and patient communities alike are showing growing interest. Moreover, the Asia-Pacific region is emerging as a significant growth engine, with supportive policies and increasing clinical trial activity in countries like China, Japan, and South Korea, paving the way for future regional commercialization strategies.

This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus Therapy.

The Oncolytic Virus Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncolytic Virus Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oncolytic Virus Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

MARKET SEGMENTATION

By Company

Amgen
RIGVIR Group
3s-guojian
Shuanghe Pharmaceutical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses

Segment by Application

Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oncolytic Virus Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oncolytic Virus Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 HSV-based Oncolytic Viruses

1.2.3 Adenoviruses-based Oncolytic Viruses

1.2.4 Vaccinia Virus-based Oncolytic Viruses

1.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses

1.2.6 Newcastle Disease Virus-based Oncolytic Viruses

1.3 Market by Application

1.3.1 Global Oncolytic Virus Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Melanoma

1.3.3 Prostate Cancer

1.3.4 Breast Cancer

1.3.5 Ovarian Cancer

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oncolytic Virus Therapy Market Perspective (2020-2031)

2.2 Global Oncolytic Virus Therapy Growth Trends by Region

2.2.1 Global Oncolytic Virus Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Oncolytic Virus Therapy Historic Market Size by Region (2020-2025)

2.2.3 Oncolytic Virus Therapy Forecasted Market Size by Region (2026-2031)

2.3 Oncolytic Virus Therapy Market Dynamics

2.3.1 Oncolytic Virus Therapy Industry Trends

2.3.2 Oncolytic Virus Therapy Market Drivers

2.3.3 Oncolytic Virus Therapy Market Challenges

2.3.4 Oncolytic Virus Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oncolytic Virus Therapy Players by Revenue

3.1.1 Global Top Oncolytic Virus Therapy Players by Revenue (2020-2025)

3.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Top Oncolytic Virus Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Oncolytic Virus Therapy Revenue

3.4 Global Oncolytic Virus Therapy Market Concentration Ratio

3.4.1 Global Oncolytic Virus Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Therapy Revenue in 2024

3.5 Global Key Players of Oncolytic Virus Therapy Head office and Area Served

3.6 Global Key Players of Oncolytic Virus Therapy, Product and Application

3.7 Global Key Players of Oncolytic Virus Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oncolytic Virus Therapy Breakdown Data by Type

4.1 Global Oncolytic Virus Therapy Historic Market Size by Type (2020-2025)

4.2 Global Oncolytic Virus Therapy Forecasted Market Size by Type (2026-2031)

5 Oncolytic Virus Therapy Breakdown Data by Application

5.1 Global Oncolytic Virus Therapy Historic Market Size by Application (2020-2025)

5.2 Global Oncolytic Virus Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Oncolytic Virus Therapy Market Size (2020-2031)

6.2 North America Oncolytic Virus Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Oncolytic Virus Therapy Market Size by Country (2020-2025)

6.4 North America Oncolytic Virus Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oncolytic Virus Therapy Market Size (2020-2031)

7.2 Europe Oncolytic Virus Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Oncolytic Virus Therapy Market Size by Country (2020-2025)

7.4 Europe Oncolytic Virus Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Oncolytic Virus Therapy Market Size (2020-2031)

8.2 Asia-Pacific Oncolytic Virus Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Oncolytic Virus Therapy Market Size (2020-2031)

9.2 Latin America Oncolytic Virus Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Oncolytic Virus Therapy Market Size by Country (2020-2025)

9.4 Latin America Oncolytic Virus Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oncolytic Virus Therapy Market Size (2020-2031)

10.2 Middle East & Africa Oncolytic Virus Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Details

11.1.2 Amgen Business Overview

11.1.3 Amgen Oncolytic Virus Therapy Introduction

11.1.4 Amgen Revenue in Oncolytic Virus Therapy Business (2020-2025)

11.1.5 Amgen Recent Development

11.2 RIGVIR Group

11.2.1 RIGVIR Group Company Details

11.2.2 RIGVIR Group Business Overview

11.2.3 RIGVIR Group Oncolytic Virus Therapy Introduction

11.2.4 RIGVIR Group Revenue in Oncolytic Virus Therapy Business (2020-2025)

11.2.5 RIGVIR Group Recent Development

11.3 3s-guojian

11.3.1 3s-guojian Company Details

11.3.2 3s-guojian Business Overview

11.3.3 3s-guojian Oncolytic Virus Therapy Introduction

11.3.4 3s-guojian Revenue in Oncolytic Virus Therapy Business (2020-2025)

11.3.5 3s-guojian Recent Development

11.4 Shuanghe Pharmaceutical

11.4.1 Shuanghe Pharmaceutical Company Details

11.4.2 Shuanghe Pharmaceutical Business Overview

11.4.3 Shuanghe Pharmaceutical Oncolytic Virus Therapy Introduction

11.4.4 Shuanghe Pharmaceutical Revenue in Oncolytic Virus Therapy Business (2020-2025)

11.4.5 Shuanghe Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Oncolytic Virus Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of HSV-based Oncolytic Viruses

Table 3. Key Players of Adenoviruses-based Oncolytic Viruses

Table 4. Key Players of Vaccinia Virus-based Oncolytic Viruses

Table 5. Key Players of Vesicular Stomatitis Virus-based Oncolytic Viruses

Table 6. Key Players of Newcastle Disease Virus-based Oncolytic Viruses

Table 7. Global Oncolytic Virus Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Oncolytic Virus Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Oncolytic Virus Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Oncolytic Virus Therapy Market Share by Region (2020-2025)

Table 11. Global Oncolytic Virus Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Oncolytic Virus Therapy Market Share by Region (2026-2031)

Table 13. Oncolytic Virus Therapy Market Trends

Table 14. Oncolytic Virus Therapy Market Drivers

Table 15. Oncolytic Virus Therapy Market Challenges

Table 16. Oncolytic Virus Therapy Market Restraints

Table 17. Global Oncolytic Virus Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Oncolytic Virus Therapy Market Share by Players (2020-2025)

Table 19. Global Top Oncolytic Virus Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2024)

Table 20. Ranking of Global Top Oncolytic Virus Therapy Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Oncolytic Virus Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Oncolytic Virus Therapy, Headquarters and Area Served

Table 23. Global Key Players of Oncolytic Virus Therapy, Product and Application

Table 24. Global Key Players of Oncolytic Virus Therapy, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Oncolytic Virus Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Oncolytic Virus Therapy Revenue Market Share by Type (2020-2025)

Table 28. Global Oncolytic Virus Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Oncolytic Virus Therapy Revenue Market Share by Type (2026-2031)

Table 30. Global Oncolytic Virus Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Oncolytic Virus Therapy Revenue Market Share by Application (2020-2025)

Table 32. Global Oncolytic Virus Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Oncolytic Virus Therapy Revenue Market Share by Application (2026-2031)

Table 34. North America Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Oncolytic Virus Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Oncolytic Virus Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Oncolytic Virus Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Oncolytic Virus Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Oncolytic Virus Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Oncolytic Virus Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Oncolytic Virus Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 49. Amgen Company Details

Table 50. Amgen Business Overview

Table 51. Amgen Oncolytic Virus Therapy Product

Table 52. Amgen Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)

Table 53. Amgen Recent Development

Table 54. RIGVIR Group Company Details

Table 55. RIGVIR Group Business Overview

Table 56. RIGVIR Group Oncolytic Virus Therapy Product

Table 57. RIGVIR Group Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)

Table 58. RIGVIR Group Recent Development

Table 59. 3s-guojian Company Details

Table 60. 3s-guojian Business Overview

Table 61. 3s-guojian Oncolytic Virus Therapy Product

Table 62. 3s-guojian Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)

Table 63. 3s-guojian Recent Development

Table 64. Shuanghe Pharmaceutical Company Details

Table 65. Shuanghe Pharmaceutical Business Overview

Table 66. Shuanghe Pharmaceutical Oncolytic Virus Therapy Product

Table 67. Shuanghe Pharmaceutical Revenue in Oncolytic Virus Therapy Business (2020-2025) & (US$ Million)

Table 68. Shuanghe Pharmaceutical Recent Development

Table 69. Research Programs/Design for This Report

Table 70. Key Data Information from Secondary Sources

Table 71. Key Data Information from Primary Sources

Table 72. Authors List of This Report

List of Figures

Figure 1. Oncolytic Virus Therapy Picture

Figure 2. Global Oncolytic Virus Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oncolytic Virus Therapy Market Share by Type: 2024 VS 2031

Figure 4. HSV-based Oncolytic Viruses Features

Figure 5. Adenoviruses-based Oncolytic Viruses Features

Figure 6. Vaccinia Virus-based Oncolytic Viruses Features

Figure 7. Vesicular Stomatitis Virus-based Oncolytic Viruses Features

Figure 8. Newcastle Disease Virus-based Oncolytic Viruses Features

Figure 9. Global Oncolytic Virus Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Oncolytic Virus Therapy Market Share by Application: 2024 VS 2031

Figure 11. Melanoma Case Studies

Figure 12. Prostate Cancer Case Studies

Figure 13. Breast Cancer Case Studies

Figure 14. Ovarian Cancer Case Studies

Figure 15. Others Case Studies

Figure 16. Oncolytic Virus Therapy Report Years Considered

Figure 17. Global Oncolytic Virus Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Oncolytic Virus Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Oncolytic Virus Therapy Market Share by Region: 2024 VS 2031

Figure 20. Global Oncolytic Virus Therapy Market Share by Players in 2024

Figure 21. Global Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 22. The Top 10 and 5 Players Market Share by Oncolytic Virus Therapy Revenue in 2024

Figure 23. North America Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Oncolytic Virus Therapy Market Share by Country (2020-2031)

Figure 25. United States Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Oncolytic Virus Therapy Market Share by Country (2020-2031)

Figure 29. Germany Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Ireland Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Oncolytic Virus Therapy Market Share by Region (2020-2031)

Figure 37. China Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia & New Zealand Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Oncolytic Virus Therapy Market Share by Country (2020-2031)

Figure 45. Mexico Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Oncolytic Virus Therapy Market Share by Country (2020-2031)

Figure 49. Israel Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Oncolytic Virus Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Amgen Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)

Figure 53. RIGVIR Group Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)

Figure 54. 3s-guojian Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)

Figure 55. Shuanghe Pharmaceutical Revenue Growth Rate in Oncolytic Virus Therapy Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Oncolytic Virus Therapy in 2025? zhanKai

The global market size of Oncolytic Virus Therapy in 2025 was 118 Million USD.

What is the annual compound growth rate of the global Oncolytic Virus Therapy market size from 2025 to 2031? shouQi

What was the global market size of Oncolytic Virus Therapy in 2031? shouQi

Which companies rank high in the global Oncolytic Virus Therapy market? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Oncolytic Virus Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Oncolytic Virus Therapy market size was US$ 118 million in 2025 and is forecast to reach a readjusted size of US$ 232 million by 2032 with a CAGR of 10.4% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 67
USD 4250.00
(Single User License)
Global Oncolytic Virus Therapy Market Research Report 2026
The global Oncolytic Virus Therapy market was valued at US$ 118 million in 2025 and is anticipated to reach US$ 232 million by 2032, at a CAGR of 10.4% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 99
USD 2900.00
(Single User License)
Oncolytic Virus Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 118 million in 2025 and is projected to reach US$ 232 million, growing at a CAGR of 10.4% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 73
USD 3950.00
(Single User License)
Oncolytic Virus Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 106 million in 2024 and is forecast to a readjusted size of US$ 213 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published Date: 2025-10-21
Pages: 77
USD 3950.00
(Single User License)
Global Oncolytic Virus Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Oncolytic Virus Therapy market is projected to grow from US$ 106 million in 2024 to US$ 213 million by 2031, at a CAGR of 10.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 103
USD 4900.00
(Single User License)
Global Oncolytic Virus Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Oncolytic Virus Therapy market size was US$ 106 million in 2024 and is forecast to a readjusted size of US$ 213 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published Date: 2025-08-13
Pages: 67
USD 4250.00
(Single User License)
Global Oncolytic Virus Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Oncolytic Virus Therapy was estimated to be worth US$ 9.3 million and is forecast to reach approximately US$ 43.3 million by 2031 with a CAGR of 24.9% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 135
USD 5900.00
(Single User License)
Oncolytic Virus Therapy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 9.3 million in 2024 and is forecast to a readjusted size of US$ 43.3 million by 2031 with a CAGR of 24.9% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 117
USD 3950.00
(Single User License)
Global Oncolytic Virus Therapy Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Published Date: 2024-04-17
Pages: 151
USD 5600.00
(Single User License)
Global Oncolytic Virus Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Published Date: 2024-04-16
Pages: 146
USD 5900.00
(Single User License)

Global Oncolytic Virus Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Oncolytic Virus Therapy market size was US$ 118 million in 2025 and is forecast to reach a readjusted size of US$ 232 million by 2032 with a CAGR of 10.4% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 67
USD 4250.00 (Single User License)
Global Oncolytic Virus Therapy Market Research Report 2026
The global Oncolytic Virus Therapy market was valued at US$ 118 million in 2025 and is anticipated to reach US$ 232 million by 2032, at a CAGR of 10.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 99
USD 2900.00 (Single User License)
Oncolytic Virus Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 118 million in 2025 and is projected to reach US$ 232 million, growing at a CAGR of 10.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 73
USD 3950.00 (Single User License)
Oncolytic Virus Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 106 million in 2024 and is forecast to a readjusted size of US$ 213 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published: 2025-10-21
Pages: 77
USD 3950.00 (Single User License)
Global Oncolytic Virus Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Oncolytic Virus Therapy market is projected to grow from US$ 106 million in 2024 to US$ 213 million by 2031, at a CAGR of 10.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 103
USD 4900.00 (Single User License)
Global Oncolytic Virus Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Oncolytic Virus Therapy market size was US$ 106 million in 2024 and is forecast to a readjusted size of US$ 213 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published: 2025-08-13
Pages: 67
USD 4250.00 (Single User License)
Global Oncolytic Virus Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Oncolytic Virus Therapy was estimated to be worth US$ 9.3 million and is forecast to reach approximately US$ 43.3 million by 2031 with a CAGR of 24.9% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 135
USD 5900.00 (Single User License)
Oncolytic Virus Therapy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 9.3 million in 2024 and is forecast to a readjusted size of US$ 43.3 million by 2031 with a CAGR of 24.9% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 117
USD 3950.00 (Single User License)
Global Oncolytic Virus Therapy Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Published: 2024-04-17
Pages: 151
USD 5600.00 (Single User License)
Global Oncolytic Virus Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Published: 2024-04-16
Pages: 146
USD 5900.00 (Single User License)